Two innovative aortic bioprostheses evaluated in the real-world setting. First results from a two-center study.
The Journal of cardiovascular surgery(2023)
摘要
INSPIRIS Resilia and AVALUS bioprostheses were reliable with comparable results in safety, clinical outcome and hemodynamic performance. After statistical adjustment, AVALUS was associated with better left ventricular mass reduction. Long-term follow-up would provide definitive comparative results.
更多查看译文
关键词
innovative aortic bioprostheses,real-world,two-center
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要